ImClone Systems Incorporated (ImClone) is a "biopharmaceutical company that develops a portfolio of targeted biologic treatments designed to address the medical needs of patients with cancer." ImClone Co. was founded in 1984. In 1986, the company opened its laboratories at 180 Varick Street in New York City. The Company focused on seclusion-based analysis and transmittable disease serums. This focus brought about two "FDA approved diagnostics" and many vaccine research programs. As time went on, the Company's focus moved from diagnostics and transmittable disease to the area of oncology.
I decided to invest in this company because it is a company that many people are not familiar with. The research that this company performs may one day find a cure for cancer and many other horrible diseases that have sprung up in today's world.
ImClone has produced a product called ERBITUX which is an antibody approved by the United States Food and Drug Administration. Their new product is used......
Join Now or Login to view the rest of this paper.
Approximate Word Count: 358
Approximate Pages: 2 (260 words per double-spaced page) |